Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1449248
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1449248
Antibiotic Resistance Market Share, Size, Trends, Industry Analysis Report, By Disease (cUTI, CDI, ABSSSI, HABP, CABP, cIAI, and BSI); By Drug Class; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
PUBLISHED:
PAGES: 116 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global antibiotic resistance market size is expected to reach USD 14.29 billion by 2032, according to a new study by Polaris Market Research. The report "Antibiotic Resistance Market Share, Size, Trends, Industry Analysis Report, By Disease (cUTI, CDI, ABSSSI, HABP, CABP, cIAI, and BSI); By Drug Class; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising proliferation of inappropriate use of antibiotics, such as over-prescription, consumption with proper medical supervision, and incomplete or improper treatment courses, all result in the development of antibiotic-resistant strains, driving the global market growth. Also, the growing need for the discovery of new antibiotics with the ability to effectively combat several antibiotic-resistant strains and R&D efforts focused on new drug classes are also likely to bode well for the market's growth. For instance, in January 2023, Alkem Laboratories announced the launch of a new antibiotic drug for the treatment of multiple drug-resistant infections. This is a novel amalgamation of ceftazidime and avibactam, which is indicated for several ailments, including complicated urinary tract infections.
As whole-genome sequencing of the antimicrobial-resistant is being widely used for antimicrobial resistance surveillance, thereby, innovations in genome sequencing and different analysis technologies could revolutionize antibiotic resistance surveillance and epidemiology.
Furthermore, there is a growing focus on research and development activities or efforts to develop or discover new antibiotics, and various government authorities and health organizations are focusing on the methods to enhance antibiotic capabilities. Also, regulatory authorities are constantly working on raising awareness among the global population about antibiotic resistance and its health effects, which are likely to impact the market positively. For instance, in October 2023, The Quadripartite announced the creation of a new Working Group on Youth Engagement, especially for antimicrobial resistance. The members of the group will notify as well as guide quadripartite efforts to raise awareness and bring the younger population into the global AMR action.
Antibiotic Resistance Market Report Highlights
Complicated urinary tract infections segment accounted for significant share in 2023, on account of growing incidences of UTIs (urinary tract infections) globally
Oxazolidinones segment held the majority share in 2023, that is attributed to its greater efficacy and effectiveness against numerous drug-resistant bacteria or pathogens
Online pharmacies segment dominated the market in 2023, due to rising number of patients opting for remote consultation and popularity of e-prescriptions and digital health records
North America dominated the global market, owing to rising incidences of infectious diseases and development of new antibiotic solutions
The key market players include Johnson & Johnson Services, Merck & Co. Inc, Pfizer Inc., Novartis AG, The Medicines Company, and Achaogen Inc.
Polaris Market Research has segmented the antibiotic resistance market report based on disease, drug type, distribution channel, and region:
Antibiotic Resistance, Disease Outlook (Revenue - USD Billion, 2023 - 2032)
- cUTI (Complicated Urinary Tract Infections)
- CDI (Clostridioides Difficile Infection)
- ABSSSI (Acute Bacterial Skin and Skin Structure Infections)
- HABP (Hospital-acquired Bacterial Pneumonia)
- CABP (Community-acquired Pneumonia)
- cIAI (Complicated Intra-abdominal Infection)
- BSI (Bloodstream Infection)
Antibiotic Resistance, Drug Class Outlook (Revenue - USD Billion, 2023 - 2032)
- Oxazolidinones
- Lipoglycopeptides
- Tetracyclines
- Combination Therapies
- Cephalosporins
- Others
Antibiotic Resistance, Distribution Channel Outlook (Revenue - USD Billion, 2023 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Antibiotic Resistance, Regional Outlook (Revenue - USD Billion, 2023 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Product Code: PM4434
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Antibiotic Resistance Market Insights
- 4.1. Antibiotic Resistance Market - Drug Class Snapshot
- 4.2. Antibiotic Resistance Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising prevalence of antibiotic-resistant and hospital-acquired infections to drive antibiotic resistance market growth
- 4.2.1.2. Growing development of new novel antibiotics boosting market's growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Stringent government regulations and requirements to hamper market growth
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Antibiotic Resistance Market Drug Class Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Antibiotic Resistance Market, by Disease
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 5.3. cUTI (Complicated Urinary Tract Infections)
- 5.3.1. Global Antibiotic Resistance Market, by cUTI (Complicated Urinary Tract Infections), by Region, 2019-2032 (USD Billion)
- 5.4. CDI (Clostridioides Difficile Infection)
- 5.4.1. Global Antibiotic Resistance Market, by CDI (Clostridioides Difficile Infection), by Region, 2019-2032 (USD Billion)
- 5.5. ABSSSI (Acute Bacterial Skin and Skin Structure Infections)
- 5.5.1. Global Antibiotic Resistance Market, by ABSSSI (Acute Bacterial Skin and Skin Structure Infections), by Region, 2019-2032 (USD Billion)
- 5.6. HABP (Hospital-acquired Bacterial Pneumonia)
- 5.6.1. Global Antibiotic Resistance Market, by HABP (Hospital-acquired Bacterial Pneumonia), by Region, 2019-2032 (USD Billion)
- 5.7. CABP (Community-acquired Pneumonia)
- 5.7.1. Global Antibiotic Resistance Market, by CABP (Community-acquired Pneumonia), by Region, 2019-2032 (USD Billion)
- 5.8. cIAI (Complicated Intra-abdominal Infection)
- 5.8.1. Global Antibiotic Resistance Market, by cIAI (Complicated Intra-abdominal Infection), by Region, 2019-2032 (USD Billion)
- 5.9. BSI (Bloodstream Infection)
- 5.9.1. Global Antibiotic Resistance Market, by BSI (Bloodstream Infection), by Region, 2019-2032 (USD Billion)
6. Global Antibiotic Resistance Market, by Distribution Channel
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 6.3. Hospital Pharmacies
- 6.3.1. Global Antibiotic Resistance Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)
- 6.4. Retail Pharmacies
- 6.4.1. Global Antibiotic Resistance Market, by Retail Pharmacies, by Region, 2019-2032 (USD Billion)
- 6.5. Online Pharmacies
- 6.5.1. Global Antibiotic Resistance Market, by Online Pharmacies, by Region, 2019-2032 (USD Billion)
7. Global Antibiotic Resistance Market, by Drug Class
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 7.3. Oxazolidinones
- 7.3.1. Global Antibiotic Resistance Market, by Oxazolidinones, By Region, 2019-2032 (USD Billion)
- 7.4. Lipoglycopeptides
- 7.4.1. Global Antibiotic Resistance Market, by Lipoglycopeptides, By Region, 2019-2032 (USD Billion)
- 7.5. Tetracyclines
- 7.5.1. Global Antibiotic Resistance Market, by Tetracyclines, By Region, 2019-2032 (USD Billion)
- 7.6. Combination Therapies
- 7.6.1. Global Antibiotic Resistance Market, by Combination Therapies, By Region, 2019-2032 (USD Billion)
- 7.7. Cephalosporins
- 7.7.1. Global Antibiotic Resistance Market, by Cephalosporins, By Region, 2019-2032 (USD Billion)
- 7.8. Others
- 7.8.1. Global Antibiotic Resistance Market, by Others, By Region, 2019-2032 (USD Billion)
8. Global Antibiotic Resistance Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Antibiotic Resistance Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Antibiotic Resistance Market - North America
- 8.3.1. North America: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.3.2. North America: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.3.3. North America: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.4. Antibiotic Resistance Market - U.S.
- 8.3.4.1. U.S.: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.5. Antibiotic Resistance Market - Canada
- 8.3.5.1. Canada: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4. Antibiotic Resistance Market - Europe
- 8.4.1. Europe: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.4.3. Europe: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.4. Antibiotic Resistance Market - UK
- 8.4.4.1. UK: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.5. Antibiotic Resistance Market - France
- 8.4.5.1. France: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.4.5.3. France: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.6. Antibiotic Resistance Market - Germany
- 8.4.6.1. Germany: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.7. Antibiotic Resistance Market - Italy
- 8.4.7.1. Italy: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.8. Antibiotic Resistance Market - Spain
- 8.4.8.1. Spain: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.9. Antibiotic Resistance Market - Netherlands
- 8.4.9.1. Netherlands: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.10. Antibiotic Resistance Market - Russia
- 8.4.10.1. Russia: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5. Antibiotic Resistance Market - Asia Pacific
- 8.5.1. Asia Pacific: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.4. Antibiotic Resistance Market - China
- 8.5.4.1. China: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.5.4.3. China: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.5. Antibiotic Resistance Market - India
- 8.5.5.1. India: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.5.5.3. India: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.6. Antibiotic Resistance Market - Malaysia
- 8.5.6.1. Malaysia: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.7. Antibiotic Resistance Market - Japan
- 8.5.7.1. Japan: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.8. Antibiotic Resistance Market - Indonesia
- 8.5.8.1. Indonesia: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.9. Antibiotic Resistance Market - South Korea
- 8.5.9.1. South Korea: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6. Antibiotic Resistance Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.4. Antibiotic Resistance Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.5. Antibiotic Resistance Market - UAE
- 8.6.5.1. UAE: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.6. Antibiotic Resistance Market - Israel
- 8.6.6.1. Israel: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.7. Antibiotic Resistance Market - South Africa
- 8.6.7.1. South Africa: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7. Antibiotic Resistance Market - Latin America
- 8.7.1. Latin America: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.4. Antibiotic Resistance Market - Mexico
- 8.7.4.1. Mexico: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.5. Antibiotic Resistance Market - Brazil
- 8.7.5.1. Brazil: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.6. Antibiotic Resistance Market - Argentina
- 8.7.6.1. Argentina: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Achaogen Inc. (US)
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. BioVersys AG (Ireland)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. CARB-X (US)
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Destiny Pharma (UK)
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. F. Hoffmann-La Roche Ltd. (Switzerland)
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Johnson & Johnson Services (US)
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Melinta Therapeutics LLC (US)
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Merck & Co. Inc. (Germany)
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Nabriva Therapeutics Plc (Ireland)
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Novartis AG (Switzerland)
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Pfizer Inc. (US)
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. The Medicines Company (US)
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Vertex Pharmaceuticals Incorporated (US)
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. West Way Health (Ireland)
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
Product Code: PM4434
List of Tables
- Table 1 Global Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 2 Global Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 3 Global Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 4 Antibiotic Resistance Market Assessment, By Geography, 2019-2032 (USD Billion)
- Table 5 North America: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 6 North America: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 7 North America: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 8 U.S.: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 9 U.S.: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 10 U.S.: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 11 Canada: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 12 Canada: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 13 Canada: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 14 Europe: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 15 Europe: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 16 Europe: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 17 UK: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 18 UK: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 19 UK: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 20 France: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 21 France: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 22 France: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 23 Germany: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 24 Germany: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 25 Germany: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 26 Italy: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 27 Italy: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 28 Italy: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 29 Spain: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 30 Spain: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 31 Spain: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 32 Netherlands: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 33 Netherlands: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 34 Netherlands: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 35 Russia: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 36 Russia: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 37 Russia: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 38 Asia Pacific: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 39 Asia Pacific: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 40 Asia Pacific: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 41 China: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 42 China: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 43 China: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 44 India: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 45 India: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 46 India: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 47 Malaysia: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 48 Malaysia: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 49 Malaysia: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 50 Japan: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 51 Japan: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 52 Japan: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 53 Indonesia: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 54 Indonesia: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 55 Indonesia: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 56 South Korea: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 57 South Korea: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 58 South Korea: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 59 Middle East & Africa: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 60 Middle East & Africa: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 61 Middle East & Africa: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 62 Saudi Arabia: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 63 Saudi Arabia: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 64 Saudi Arabia: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 65 UAE: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 66 UAE: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 67 UAE: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 68 Israel: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 69 Israel: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 70 Israel: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 71 South Africa: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 72 South Africa: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 73 South Africa: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 74 Latin America: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 75 Latin America: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 76 Latin America: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 77 Mexico: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 78 Mexico: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 79 Mexico: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 80 Brazil: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 81 Brazil: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 82 Brazil: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
- Table 83 Argentina: Antibiotic Resistance Market, by Disease, 2019-2032 (USD Billion)
- Table 84 Argentina: Antibiotic Resistance Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 85 Argentina: Antibiotic Resistance Market, by Drug Class, 2019-2032 (USD Billion)
List of Figures
- Figure 1. Global Antibiotic Resistance Market, 2019-2032 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Distribution Channel
- Figure 7. Global Antibiotic Resistance Market, by Distribution Channel, 2022 & 2032 (USD Billion)
- Figure 8. Market by Disease
- Figure 9. Global Antibiotic Resistance Market, by Disease, 2022 & 2032 (USD Billion)
- Figure 10. Market by Drug Class
- Figure 11. Global Antibiotic Resistance Market, by Drug Class, 2022 & 2032 (USD Billion)
- Figure 12. Antibiotic Resistance Market Assessment, By Geography, 2019-2032 (USD Billion)
- Figure 13. Strategic Analysis - Antibiotic Resistance Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.